First Time Loading...

Exact Sciences Corp
NASDAQ:EXAS

Watchlist Manager
Exact Sciences Corp Logo
Exact Sciences Corp
NASDAQ:EXAS
Watchlist
Price: 50.38 USD -3.02% Market Closed
Updated: May 18, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

6.4B
-1%
Assets
Growth Rates:
1 Year
+1%
3 Years
-5%
5 Years
+260%
7 Years
+1 720%
10 Years
+4 655%
3.2B
-2%
Liabilities
Growth Rates:
1 Year
0%
3 Years
+5%
5 Years
+226%
7 Years
+7 870%
10 Years
+26 059%
3.1B
-0.4%
Equity
Growth Rates:
1 Year
+2%
3 Years
-14%
5 Years
+303%
7 Years
+912%
10 Years
+2 472%

Balance Sheet Decomposition
Exact Sciences Corp

6.4B
Assets
3.2B
Liabilities
6.4B
Assets
3.2B
Liabilities
Current Assets 1.1B
Cash & Short-Term Investments 652.1m
Receivables 240.6m
Other Current Assets 227.6m
Non-Current Assets 5.3B
PP&E 862.7m
Intangibles 4.2B
Other Non-Current Assets 159.5m
Current Liabilities 685.1m
Accounts Payable 60.5m
Accrued Liabilities 292.3m
Other Current Liabilities 332.3m
Non-Current Liabilities 2.6B
Long-Term Debt 2.1B
Other Non-Current Liabilities 478.7m

Balance Sheet
Exact Sciences Corp

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
58
41
49
78
160
177
1 491
315
243
605
Cash
0
0
0
0
0
0
0
247
178
530
Cash Equivalents
58
41
49
78
160
177
1 491
68
64
75
Short-Term Investments
225
266
262
347
964
146
349
715
390
172
Total Receivables
1
5
9
26
44
130
233
217
158
204
Accounts Receivables
1
5
9
26
44
130
233
217
158
204
Other Receivables
0
0
0
0
0
0
0
0
0
0
Inventory
4
7
7
26
39
62
92
105
118
127
Other Current Assets
4
7
7
10
21
38
33
74
74
86
Total Current Assets
292
326
334
487
1 228
554
2 199
1 426
982
1 194
PP&E Net
20
34
38
80
245
582
597
773
862
853
PP&E Gross
20
34
38
80
245
582
597
773
862
853
Accumulated Depreciation
6
14
25
38
58
78
138
215
308
417
Intangible Assets
0
0
0
22
29
1 144
847
2 094
1 956
1 890
Goodwill
0
0
0
0
17
1 203
1 238
2 335
2 346
2 367
Other Long-Term Assets
1
4
5
9
4
23
45
56
80
166
Other Assets
0
0
0
0
17
1 203
1 238
2 335
2 346
2 367
Total Assets
313
N/A
364
+16%
377
+4%
599
+59%
1 524
+155%
3 506
+130%
4 925
+40%
6 685
+36%
6 227
-7%
6 471
+4%
Liabilities
Accounts Payable
3
3
1
16
28
26
36
68
75
79
Accrued Liabilities
14
22
28
49
105
201
245
418
328
371
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
1
319
6
3
62
Other Current Liabilities
1
1
2
3
3
8
34
25
7
3
Total Current Liabilities
18
27
31
68
136
237
633
517
413
515
Long-Term Debt
1
5
5
4
689
828
1 898
2 193
2 244
2 322
Other Liabilities
5
6
6
6
18
153
158
587
528
490
Total Liabilities
24
N/A
37
+56%
42
+12%
78
+87%
843
+980%
1 218
+44%
2 690
+121%
3 297
+23%
3 184
-3%
3 326
+4%
Equity
Common Stock
1
1
1
1
1
2
2
2
2
2
Retained Earnings
421
579
746
861
1 036
1 120
2 046
2 642
3 265
3 469
Additional Paid In Capital
709
905
1 080
1 381
1 717
3 406
4 279
6 029
6 312
6 611
Unrealized Security Profit/Loss
0
0
0
1
1
0
1
2
5
0
Other Equity
0
0
0
0
0
0
0
0
0
1
Total Equity
289
N/A
327
+13%
335
+3%
520
+55%
681
+31%
2 288
+236%
2 236
-2%
3 388
+52%
3 043
-10%
3 145
+3%
Total Liabilities & Equity
313
N/A
364
+16%
377
+4%
599
+59%
1 524
+155%
3 506
+130%
4 925
+40%
6 685
+36%
6 227
-7%
6 471
+4%
Shares Outstanding
Common Shares Outstanding
89
97
110
121
123
148
159
174
178
181

See Also

Summary
EXAS intrinsic value, competitors valuation, and company profile.
DCF Valuation
EXAS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EXAS stock valuation using valuation multiples.
Wall Street Estimates
EXAS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EXAS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 138,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.